HDAC1 and prostate carcinoma: PEITC treatment of LNCaP prostate cancer cell line significantly reduced the protein levels of HDAC1, 2, 4, and 6 that correlated with promoter demethylation and activation of a tumor suppressor gene, RASSF1A (Boyanapalli et al., 2016).